RECOMMENDATIONS FOR THE SAFE HANDLING OF INJECTABLE ANTI-NEOPLASTIC DRUG PRODUCTS

被引：62

作者：

ZIMMERMAN, PF ^{[1
]}

LARSEN, RK ^{[1
]}

BARKLEY, EW ^{[1
]}

GALLELLI, JF ^{[1
]}

机构：

[1] NIH,OFF RES SERV,DIV SAFETY,OCCUPAT SAFETY & HLTH BRANCH,BETHESDA,MD 20205

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1981年 / 38卷 / 11期

关键词：

D O I：

10.1093/ajhp/38.11.1693

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1693 / 1695

页数：3

共 11 条

[1]

[Anonymous], 1981, Hosp Pharm, V16, P17

[2]

FALCK K, 1979, LANCET, V1, P1250

[3]

HARRIS CC, 1976, CANCER-AM CANCER SOC, V37, P1014, DOI 10.1002/1097-0142(197602)37:2+<1014::AID-CNCR2820370805>3.0.CO

[4]

2-Z

[5]

HOFFMAN D M, 1980, Hospital Pharmacy, V15, P302

[6] HANDLING OF INJECTABLE ANTI-NEOPLASTIC AGENTS [J].

KNOWLES, RS ;

VIRDEN, JE .

BRITISH MEDICAL JOURNAL, 1980, 281 (6240) :589-591

[7] ACUTE-LEUKEMIA AFTER ALKYLATING-AGENT THERAPY OF OVARIAN CANCER [J].

REIMER, RR ;

HOOVER, R ;

FRAUMENI, JF ;

YOUNG, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (04) :177-181

[8]

ROSNER F, 1976, CANCER, V37, P1033, DOI 10.1002/1097-0142(197602)37:2+<1033::AID-CNCR2820370807>3.0.CO

[9]

2-U

[10]

Sieber S M, 1975, Adv Cancer Res, V22, P57

← 1 2 →